No Data
No Data
Syndax Pharmaceuticals' (NASDAQ:SNDX) Growing Losses Don't Faze Investors as the Stock Climbs 4.4% This Past Week
Citi Maintains Syndax Pharmaceuticals(SNDX.US) With Buy Rating, Raises Target Price to $34
Syndax Pharmaceuticals Is Maintained at Buy by Citigroup
A Quick Look at Today's Ratings for Syndax Pharmaceuticals(SNDX.US), With a Forecast Between $31 to $45
Express News | Syndax Pharmaceuticals Inc : Citigroup Raises Target Price to $34 From $30
Syndax Pharmaceuticals Is Maintained at Buy by HC Wainwright & Co.
No Data